135 related articles for article (PubMed ID: 38556263)
1. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract][Full Text] [Related]
2. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
Nguyen C; Edgley AJ; Kelly DJ; Kompa AR
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202128
[TBL] [Abstract][Full Text] [Related]
3. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
[TBL] [Abstract][Full Text] [Related]
4. Indoxyl glucuronide, a protein-bound uremic toxin, inhibits hypoxia-inducible factor‒dependent erythropoietin expression through activation of aryl hydrocarbon receptor.
Asai H; Hirata J; Watanabe-Akanuma M
Biochem Biophys Res Commun; 2018 Oct; 504(2):538-544. PubMed ID: 30205954
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV attenuates indoxyl sulfate-induced injury of renal tubular epithelial cells by inhibiting the aryl hydrocarbon receptor pathway.
Mo Y; Hu D; Yu W; Ji C; Li Y; Liu X; Lu Z
J Ethnopharmacol; 2023 May; 308():116244. PubMed ID: 36764562
[TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation.
Adelibieke Y; Shimizu H; Saito S; Mironova R; Niwa T
Circ J; 2013; 77(5):1326-36. PubMed ID: 23337206
[TBL] [Abstract][Full Text] [Related]
8. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
[TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate impairs angiogenesis via chronic aryl hydrocarbon receptor activation.
Salyers ZR; Coleman M; Balestrieri NP; Ryan TE
Am J Physiol Cell Physiol; 2021 Feb; 320(2):C240-C249. PubMed ID: 33406025
[TBL] [Abstract][Full Text] [Related]
10. Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.
Ichii O; Otsuka-Kanazawa S; Nakamura T; Ueno M; Kon Y; Chen W; Rosenberg AZ; Kopp JB
PLoS One; 2014; 9(9):e108448. PubMed ID: 25244654
[TBL] [Abstract][Full Text] [Related]
11. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway.
Gondouin B; Cerini C; Dou L; Sallée M; Duval-Sabatier A; Pletinck A; Calaf R; Lacroix R; Jourde-Chiche N; Poitevin S; Arnaud L; Vanholder R; Brunet P; Dignat-George F; Burtey S
Kidney Int; 2013 Oct; 84(4):733-44. PubMed ID: 23636172
[TBL] [Abstract][Full Text] [Related]
12. Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
Wakamatsu T; Yamamoto S; Ito T; Sato Y; Matsuo K; Takahashi Y; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29543732
[TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease.
Kamiński T; Michałowska M; Pawlak D
Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957
[TBL] [Abstract][Full Text] [Related]
14. Indoxyl sulfate induces nephrovascular senescence.
Niwa T; Shimizu H
J Ren Nutr; 2012 Jan; 22(1):102-6. PubMed ID: 22200425
[TBL] [Abstract][Full Text] [Related]
15. Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
Assefa EG; Yan Q; Gezahegn SB; Salissou MTM; He S; Wu N; Zuo X; Ying C
Oxid Med Cell Longev; 2019; 2019():5847040. PubMed ID: 31885805
[TBL] [Abstract][Full Text] [Related]
16. Indoxyl sulfate downregulates expression of Mas receptor via OAT3/AhR/Stat3 pathway in proximal tubular cells.
Ng HY; Yisireyili M; Saito S; Lee CT; Adelibieke Y; Nishijima F; Niwa T
PLoS One; 2014; 9(3):e91517. PubMed ID: 24614509
[TBL] [Abstract][Full Text] [Related]
17. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
[TBL] [Abstract][Full Text] [Related]
18. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate.
Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M
Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638
[TBL] [Abstract][Full Text] [Related]
19. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells.
Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H
Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707
[TBL] [Abstract][Full Text] [Related]
20. Indoxyl Sulfate Promotes Metastatic Characteristics of Ovarian Cancer Cells via Aryl Hydrocarbon Receptor-Mediated Downregulation of the Mas Receptor.
Saito S; Koya Y; Kajiyama H; Yamashita M; Nawa A
Lab Invest; 2023 Mar; 103(3):100025. PubMed ID: 36925201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
